US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

LeMaitre Vascular Inc

us-stock
To Invest in {{usstockname}}
us-stock
$84.92 0.0148(1.48%) LMAT at 04 Dec 2025 04:37 PM Medical Instruments & Supplies
Lowest Today 83
Highest Today 84.755
Today’s Open 83.29
Prev. Close 83.68
52 Week High 104.58
52 Week Low 70.94
Day’s Range: Low 83 High 84.755
52-Week Range: Low 70.94 High 104.58
1 day return -
1 Week return +2.28
1 month return -2.64
3 month return -12.54
6 month return +3.11
1 year return -16.96
3 year return +84.56
5 year return +126.92
10 year return -

Institutional Holdings

BlackRock Inc 14.05

Conestoga Capital Advisors, LLC 7.08

Vanguard Group Inc 7.08

iShares Core S&P Small-Cap ETF 5.40

Conestoga Small Cap Investors 4.93

Copeland Capital Management, LLC 4.37

Geneva Capital Management 4.04

State Street Corp 3.58

Congress Asset Management Company, LLP 2.98

Vanguard Total Stock Mkt Idx Inv 2.84

First Trust Advisors L.P. 2.70

First Trust SMID Cp Rising Div Achv ETF 2.56

Geode Capital Management, LLC 2.30

Conestoga Small Cap Growth 2.29

Ranger Investment Management LP 2.27

iShares Russell 2000 ETF 2.23

Dimensional Fund Advisors, Inc. 2.04

Morgan Stanley - Brokerage Accounts 1.80

Congress Small Cap Growth Institutional 1.70

Ranger Small Cap 1.59

Northern Trust Corp 1.52

Nationwide Geneva Small Cap Gr Instl Svc 1.42

Royal Bank of Canada 1.38

Envestnet Asset Management Inc 1.35

Millennium Management LLC 1.28

Rockefeller Capital Management L.P. 1.28

T. Rowe Price Associates, Inc. 1.27

Acadian Asset Management LLC 1.14

Kayne Anderson Rudnick Investment Management LLC 1.07

Vanguard Institutional Extnd Mkt Idx Tr 0.97

T. Rowe Price Integrated US SmCapGrEq 0.93

T. Rowe Price Integrated US Sm Gr Eq 0.93

Fidelity Small Cap Index 0.92

iShares Russell 2000 Growth ETF 0.81

JNL Multi-Manager Small Cap Growth A 0.81

KAR Small-Mid Cap Growth 0.81

SPDR® Portfolio S&P 600™ Sm Cap ETF 0.80

iShares S&P Small-Cap 600 Growth ETF 0.78

Multi-Manager Small Cap Eq Strat Inst 0.75

DF Dent Small Cap Growth 0.63

Market Status

Strong Buy: 3

Buy: 2

Hold: 6

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 1898.36 M

PB Ratio 4.962

PE Ratio 36.069

Enterprise Value 1722.79 M

Total Assets 551.82 M

Volume 143766

Company Financials

Annual Revenue FY23:185555000 185.6M, FY22:161651000 161.7M, FY21:154424000 154.4M, FY20:129366000 129.4M, FY19:117232000 117.2M

Annual Profit FY23:119838000 119.8M, FY22:104896000 104.9M, FY21:101382000 101.4M, FY20:84618000 84.6M, FY19:79853000 79.9M

Annual Net worth FY23:27267000 27.3M, FY22:20636000 20.6M, FY21:26907000 26.9M, FY20:21220000 21.2M, FY19:17934000 17.9M

Quarterly Revenue Q3/2025:61046000 61.0M, Q2/2025:64232000 64.2M, Q1/2025:59871000 59.9M, Q3/2024:54819000 54.8M, Q2/2024:55849000 55.8M

Quarterly Profit Q3/2025:45955000 46.0M, Q2/2025:44974000 45.0M, Q1/2025:41420000 41.4M, Q3/2024:37178000 37.2M, Q2/2024:36996000 37.0M

Quarterly Net worth Q3/2025:17362000 17.4M, Q2/2025:13779000 13.8M, Q1/2025:11011000 11.0M, Q3/2024:11141000 11.1M, Q2/2024:11826000 11.8M

Fund house & investment objective

Company Information LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It also provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular and porcine patches; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Organisation Medical Instruments & Supplies

Employees 651

Industry Medical Instruments & Supplies

CEO Mr. George W. LeMaitre

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right